Symbicort 160 / 4.5 mcg 60 doses

Tradename

Symbicort

Symbicort

Composition

budesonide micronized 160 mcg

formoterol fumarate dihydrate 4.5 mcg

Auxiliary components:

lactose monohydrate — 730 mcg.

Properties

Symbicort@ contains budesonide and formoterol, which have different mechanisms of action and exhibit an additive effect in reducing the frequency of exacerbations of bronchial asthma. The special properties of budesonide and formoterol make it possible to use their combination to relieve attacks / symptoms with anti-inflammatory action, or as a supportive therapy for bronchial asthma.

Indications

bronchial asthma, in order to achieve gener control of the disease, including prevention and relief of symptoms, and reduce the risk of exacerbations, also for the treatment of bronchial asthma of any severity, if it is advisable to use inhaled GCS;

COPD, as symptomatic therapy in patients with post-bronchodilatory FEVI < 70% of the expected value and with a history of exacerbations, despite regular therapy with bronchodilators.

Mode of application:

Contraindications

-increased sensitivity to budesonide, formoterol or inhaled lactose;

-Children under 6 years old;

lactose intolerance, lactase deficiency or glucose-galactose malabsorption).

Side effects

From the nervous system: often headache; anxiety, nausea, dizziness, sleep disturbances;

On the part of the cardiovascular system: often palpitations;

From the respiratory system: often candidiasis of the mucous membrane of the mouth and pharynx, cough, hoarseness, slight irritation in the throat;